Safety of Low-Dose Aprotinin in Coronary Artery Bypass Graft Surgery: A Single-Centre Investigation in 2436 Patients in Germany

By Kluth Mario  

Drug Safety, Vol. 31, Iss. 7, 2008-01 ,pp. : 617-626

Adis International

Access to resources Recommend Favorite

Statins and coronary artery bypass graft surgery: preoperative and postoperative efficacy and safety

By Kulik Alexander   Ruel Marc  

Expert Opinion on Drug Safety, Vol. 8, Iss. 5, 2009-09 ,pp. : 559-571

Informa Healthcare

Access to resources Recommend Favorite

Meta-Analysis of Placebo-Controlled Trials of Aprotinin Assessing the Relative Risk of Reoperations in Patients Undergoing Coronary Artery Bypass Graft Surgery

By Kübler J.   Hecker-Barth G.  

Clinical Drug Investigation, Vol. 19, Iss. 3, 2000-03 ,pp. : 167-171

Adis International

Access to resources Recommend Favorite

Comparison of the Effects of Nicardipine and Sodium Nitroprusside for Control of Increased Blood Pressure after Coronary Artery Bypass Graft Surgery

By Kwak YL   Oh YJ   Bang SO   Lee JH   Jeong SM   Hong YW  

The Journal of International Medical Research, Vol. 32, Iss. 4, 2004-07 ,pp. : 342-350

Field House Publishing

Access to resources Recommend Favorite

Spontaneous baroreflex sensitivity after coronary artery bypass graft surgery as a function of gender and age

By Brown C A.   Wolfe Larry A   Hains Sylvia   Ropchan Glorianne   Parlow Joel  

Canadian Journal of Physiology and Pharmacology, Vol. 81, Iss. 9, 2003-09 ,pp. : 894-902

NRC Research Press

Access to resources Recommend Favorite